Wal-Mart Cuts September Growth Targets

Walgreen posts weaker results; Osteotech withdraws guidance; plus more of today's stocks in the news

Bone transplant maker Osteotech (OSTE ) withdrew its 2002 guidance of $0.22-$0.24 EPS on $91.5 million to $93.5 million revenue as a result of voluntarily suspending its Base Tissue unit for five to nine days due to higher than normal sterility failures.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.